Dr Kevin Fernando provides a practical overview of the utility of sodium–glucose cotransporter 2 inhibitors, focusing on dosing, cardiovascular and renal safety and the management of adverse events, including dehydration and genital infections.
Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.
Would you like to receive updates about new podcast episodes by email? (You can unsubscribe at any time)